拼接的药理学干扰引起SMG1的减少:对癌症治疗的影响
Martin Barainka1, Angelina Zheleva1, Angela Pérez-Cervera1
1Therapeutic Innovation Program, Center for Applied Medical Research, University of Navarra, Pamplona, Spain.
iScience
|February 2, 2026
概括
拼接调节剂通过抑制无意中介mRNA衰变 (NMD) 来增强瘤免疫性,稳定促进癌症的转录. 这种双重作用促进了新抗原的产生,并选择性地准了依赖NMD的瘤.
科学领域:
- 分子生物学分子生物学
- 癌症研究 癌症研究
- 免疫学 免疫学 免疫学
背景情况:
- 无意义介导的mRNA衰变 (NMD) 是一种关键的RNA监测途径,针对的是过早终止的编码子 (PTC).
- 在癌症免疫学中,NMD和mRNA拼接之间的相互作用尚未得到充分理解.
- 虽然NMD影响瘤抗原性和免疫逃避,但它与拼接调节的联系需要进一步调查.
研究的目的:
- 阐明拼接调节器影响瘤免疫性和NMD的机制.
- 调查针对癌症治疗的拼接-NMD轴的潜力.
- 探索SMG1在拼接介导的NMD抑制中的作用.
主要方法:
- 研究了拼接调节剂对NMD活动和含有PTC的转录物的影响.
- 评估了拼接调制对新抗原生成和瘤细胞细胞毒性的影响.
- 分析了患者瘤数据,以将SMG1表达与拼接调节器活性相关联.
主要成果:
- 拼接调节器通过降低SMG1的调节来抑制NMD,从而稳定了含有PTC的转录.
- 由调节器诱导的异常拼接会产生新抗原,增强瘤免疫性.
- 拼接调制显示在依赖于NMD的微卫星不稳定性 (MSI) 瘤中增强了细胞毒性.
结论:
- 拼接调节剂作为无意的NMD抑制剂,同时增加瘤抗原性.
- 这些发现揭示了一种新的治疗策略,通过拼接调制准了NMD成的瘤.
- 建立了拼接调节和瘤中NMD活性之间的功能联系.
相关概念视频
RNA Splicing
60.6K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
60.6K
Alternative RNA Splicing
25.2K
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
25.2K
Alternative RNA Splicing
5.1K
5.1K
Cancer Therapies
10.2K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.2K
Targeted Cancer Therapies
8.9K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.9K
Oxidation-Reduction Reactions
75.7K
Oxidation–Reduction Reactions
75.7K


